News Q&A |
Featured
-
-
Feature |
Biomedical research: Growing with the flow
A US court case is making stem-cell researchers nervous. But the field continues to thrive.
- Meredith Wadman
-
Spotlight |
Spotlight on Stem Cell Research
-
News Feature |
Stem cells: The growing pains of pluripotency
The field of induced pluripotent stem cells has grown up fast. Now it is entering the difficult stage.
- Erika Check Hayden
-
News |
Reprogrammed cells repair damaged livers
Proof-of-principle study could point the way to averting the need for liver transplants.
- Heidi Ledford
-
News |
US stem-cell funding ban overturned
Appeals court decision bodes well for continued NIH support of controversial research.
- Meredith Wadman
-
News |
Stem cells make 'retina in a dish'
Mouse cells have been coaxed into forming a retina, the most complex tissue yet engineered.
- Ewen Callaway
-
News |
Muscular dystrophy findings fuel French stem cell debate
Work shows the value of human embryonic stem cells for disease research.
- Alison Abbott
-
News |
Europe rules against stem-cell patents
Work with human embryonic stem cells is 'contrary to ethics'.
- Alison Abbott
-
News |
Hidden toll of embryo ethics war
Federal funds continue to be withheld for stem cells derived without destroying embryos.
- Heidi Ledford
-
News |
European Court of Justice rejects stem-cell patents
Researchers surprised by judge's conservative stance.
- Alison Abbott
-
-
News Feature |
Stem cells: The crusader
Theresa Deisher once shunned religion for science. Now, with renewed faith, she is fighting human-embryonic-stem-cell research in court.
- Meredith Wadman
-
News |
Flaw in induced-stem-cell model
Adult cells do not fully convert to embryonic-like state.
- Elie Dolgin
-
News |
France mulls embryo research reform
Scientists and clinicians push for a clearer, more permissive law on human embryonic stem-cell work.
- Declan Butler
-
News |
Cells snag top modelling job
Heart disorder joins growing list of conditions getting the 'disease in a dish' treatment.
- Ewen Callaway
-
-
News Feature |
Stem cells: The impatient advocate
Bob Klein founded the California Institute for Regenerative Medicine, the biggest state-run research project in US history. What legacy will he leave behind?
- Elie Dolgin
-
Q&A |
Turning point: Jacob Hanna
Palestinian researcher heads to Israel to foster scientific exchange.
- Virginia Gewin
-
Comment |
Long shadow of the stem–cell ruling
Two months on from the court decision that briefly suspended US federal funding for human embryonic stem-cell research, uncertainty still stalks the field. Here an ethicist, a team of bankers and a lawyer warn of effects of this saga that could be felt for years to come.
-
News |
Mystery fraud accusations
Stem-cell researchers targeted by e-mails from unidentified group.
- Heidi Ledford
-
Letter |
A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity
Realizing the full potential of human embryonic stem cells (hESCs) in research and clinical applications requires a detailed understanding of the genetic network that governs their unique properties. A genome-wide RNA interference screen identifies a wealth of new regulators of self-renewal and pluripotency properties in hESCs. The transcription factor PRDM14, for example, is required for the maintenance of hESC identity and reprogramming of somatic cells to pluripotency.
- Na-Yu Chia
- , Yun-Shen Chan
- & Huck-Hui Ng
-
News |
US midterm elections: NIH prepares for loss of political champions
Supporters call for Congress to pass stem-cell bill and NIH budget boost during post-election session.
- Meredith Wadman
-
Editorial |
Stem-cell laws in China fall short
The Chinese government's regulations of stem-cell treatments are admirable in principle, but tougher enforcement measures are needed to protect patients.
-
News |
Baby boom bags Nobel prize
UK pioneer of in vitro fertilization wins medicine honour.
- Alison Abbott
-
News |
Stem cells: A legal round table
Our expert panel examines the recent stem cell injunction from all angles.
- Meredith Wadman
-
-
-
News |
Temporary reprieve for stem cells
Scientists face a rollercoaster ride as the NIH rushes to distribute funds.
- Meredith Wadman
-
News |
US stem-cell chaos felt abroad
Court ruling endangers international partnerships.
- Meredith Wadman
-
-
News |
Stem-cell work thrown into limbo
US district-court ruling suspends federal funding for research involving human embryonic stem cells.
- Meredith Wadman
-
News |
US court suspends research on human embryonic stem cells
Effects of injunction against Obama administration's stem-cell policy still unclear.
- Alla Katsnelson
-
Research Highlights |
Stem cells: Blood source
-
Editorial |
A dangerous precedent
A legal challenge to US stem-cell policy poses a serious threat to the federal funding system.
-
-
Editorial |
Order from chaos
Much tighter regulations are needed to reap the full benefits of stem-cell treatments.
-
-
-
News |
Postdocs reap stem-cell funding benefits
Research grants offer new posts and routes to independence.
- Karen Kaplan
-
Spotlight |
Spotlight on Stem Cell Research
-
-
News |
Stem-cell funding in sight
Most popular cell lines close to approval for US federal funding.
- Meredith Wadman
-
News |
Gene flaw found in induced stem cells
Key difference between reprogrammed adult mouse cells and embryonic stem cells discovered.
- Elie Dolgin
-
News |
Stem-cell line given the nod
NIH moves to approve cells in limbo after rule change.
- Brendan Borrell